UNSPSC 85733533: Supplement right ureter with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right ureter with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TU64KZ

UNSPSC 85733533 Supplement right ureter with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not reflect the work actually being solicited by state and local governments in recent opportunities. The code appears to name a specific surgical procedure, yet recent state and local solicitations tagged under this code procure administrative medical services, occupational health surveillance, pharmacy benefit management, and temporary health professional staffing — none of which align with surgical supply or urological procedure scope. The mismatch between the code's nominal scope and the actual work being bought suggests this code sees little relevant recent activity in the state and local procurement market.

The few opportunities posted under this code span diverse issuing bodies including city retirement offices, municipal health benefits programs, state transportation agencies, county juvenile justice departments, and county health systems, with no pattern of repeat buying or concentrated purchasing activity. Geographic activity appears scattered across Arizona, California, Florida, and Washington, with no dominant regional concentration. The representative opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the City of Long Beach's RFP for surgical benefits carve-out management (HR26753, due October 7, 2026), and the Washington State Department of Transportation's RFQ for occupational medical surveillance (RFP20260825, due October 9, 2026). The code does not provide a reliable signal for procurement pipeline activity, and business development professionals should treat recent tags under this code as potential data quality issues rather than indicators of sustained demand.